Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |